David Zidar MD | University Hospitals

Clinical Trial at UH Seeks to Improve Outcomes for TAVR Patients

Two anti-platelet drugs studied for their effect on platelet function and immune activation post-procedure Innovations in Cardiovascular Medicine & Surgery - Fall 2018 David A. Zidar, MD, PhD Transcatheter aortic valve replacement (TAVR) has...

10/8/2018 By David Zidar, MD

Statins Under-Prescribed in the Young with Severe Dyslipidemia

Harrington Heart & Vascular Institute Innovations | Winter 2017

1/29/2017 By David Zidar, MD

Making the Case for CT CORONARY CALCIUM SCORING

Harrington Heart & Vascular Institute Innovations | Spring 2016

1/16/2017 By David Zidar, MD and Robert C. Gilkeson, MD

Asking Questions Giving Options

New clinical trials open for advanced LV heart failure, chelation therapy and renal denervation for treatment-resistant hypertension Guilherme Oliveira, MD Sahil Parikh, MD David Zidar, MD, PHD Harrington Heart & Vascular Institute Innovations...

8/17/2016 By Guilherme Oliveira, MD and David Zidar, MD